News Release

News release from Sutter Health’s Alta Bates Summit Medical Center in Oakland and Berkeley, California

Alta Bates Summit’s East Bay AIDS Center Has Been Making a Positive Impact for 30 Years

Posted on Nov 30, 2017

For more than 30 years, Sutter Health’s East Bay AIDS Center (EBAC) at Alta Bates Summit Medical Center has been a recognized leader in providing critical primary care services for low-income people living with HIV in Alameda and Contra Costa Counties. Founded in 1987, EBAC is dedicated to the care and treatment of people living with HIV and AIDS, and conducts a broad range of programs and projects designed to better serve these populations.

Although progress has been made nationally in reducing overall rates of new HIV infections, rates are rising among young gay and bisexual men of color in Oakland, Richmond, Berkeley and other East Bay communities.

EBAC is deeply engaged in trying to stem that rising tide. Treating those in the community who are already HIV-positive not only can restore their own health, but can also virtually eliminate their risk of transmitting HIV to others.  EBAC also now offers intensive preventive care for those who are HIV-negative but at risk of acquiring the infection.  These services include providing medications proven to dramatically reduce the risk of HIV infection. 

“We want to break down barriers preventing young people from seeking help, and reduce the impact of HIV on our community,” says Jeffrey Burack, M.D., M.P.P., co-medical director of EBAC. “Through our outreach and education programs we want to identify individuals who should be HIV tested and who may not have access to compassionate, non-judgmental sexual health care. If you are HIV negative, we want to help you develop a personalized plan to stay negative. If you are positive, we want to help get you into successful treatment.” Read More

Alta Bates Summit Medical Center Recognizes Sepsis Awareness Month

Posted on Sep 7, 2017

According to the National Institutes of Health (NIH), there are more than 1.5 million cases of sepsis a year in the United States, and up to 250,000 deaths. Sepsis is the 10th most common cause of death for Americans, yet, nearly 30 percent have never heard of it.

“Sepsis is the number one cause of mortality in our medical center,” says Denise Navellier, R.N., Alta Bates Summit Chief Nursing Executive and Sespis Initiative Executive Sponsor. “The overwhelming engagement in our sepsis initiative by our front line staff and providers has been the key to success in decreasing the overall mortality.”

Read More

Sutter Health’s 2014 Year in Review

Posted on Jul 2, 2015

Our not-for-profit Sutter Health network invites you to explore our online 2014 annual report.

Through videos and other interactive features, see how our doctors, hospitals and medical teams partner to provide top-rated, personalized care in diverse communities across Northern California.

This year our annual report focuses on our:

“At Sutter Health, we understand that in a rapidly changing world we must re-imagine how we operate if we want to continue delivering the kind of quality care our patients expect and deserve,” said Sutter Health President and CEO Pat Fry. “In 2014, we implemented advanced technologies, pursued groundbreaking research, streamlined work processes and launched more convenient ways to access care.”

Warriors Fans Come in All Sizes

Posted on Jun 16, 2015

$RFOUGJ5Thanks to a gift from Better Health East Bay, a Sutter Health philanthropic organization, newborns and their families at Alta Bates Summit Medical Center show their support for the Warriors. Alta Bates Summit delivers about 6,500 babies each year.

$5 Million Gift Provides Faster, Safer Radiation Treatment

Posted on Jun 12, 2015

?????????Thanks to a $5 million donation by Better Health East Bay, many of our cancer patients now spend less time receiving state-of-the-art radiation treatment and more time doing what they enjoy.

The investment by Sutter Health’s East Bay philanthropic foundation brings a TrueBeam STx linear accelerator to the Comprehensive Cancer Center. The machine delivers radiation to eliminate tumors with improved accuracy and safety.

“The new TrueBeam ma­chine has brought us huge strides forward in offering the very latest and best treat­ments to the patients we serve,” says Ronny Chin, Ph.D., director of medical physics and radiation services for the Comprehensive Cancer Center. “The up­grade allows us to deliver certain radiation therapies six to eight times faster than our previous machines.” Read More

Insight into Flibanserin, Women’s Libido Drug

Posted on Jun 5, 2015


Risa Kagan, M.D., is nationally recognized for her work in the field of menopause.

Alta Bates Summit and Sutter East Bay Medical Foundation OB/GYN, Risa Kagan, M.D., was  a principal investigator for flibanserin, a women’s libido drug that has taken a step toward FDA approval.

On June 4, the FDA’s joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee determined by an 18 to 6 vote that the benefit/risk profile of flibanserin supports FDA approval of the new drug for treatment of low libido in premenopausal women — if certain risk management options beyond labeling are implemented.

“There are currently no drugs approved for female sexual function (while there are 26 drugs approved for males). With this vote we are one step closer to having an approved option for women,” Kagan says.

“We can have a safety discussion that is well-informed, monitored and updated, as opposed to the quackery and off-label treatments patients currently resort to,” she adds.

Dr. Kagan’s  research was done in conjunction with Alta Bates Summit’s REDI (Jordan Research and Education Institute).